Pricing and Market Access

Reducing friction in deal making

A strong Pricing and Market Access strategy is integral to what it takes to bring a product to market and is, therefore, integral to deal making. Pricing assumptions can have an enormous impact on the valuation of an asset and are frequently a cause of misalignment with potential partners. A strong pricing narrative and a solid data generation plan to support it, is essential for success.

Expert validation of recommendations

PharmaVentures provides expert validation of recommendations for price assumptions and ensures there is a robust plan in place to achieve market access and reimbursement, consistent with the development stage of an asset. We aim to give clients certainty in pricing and market access assumptions, to increase confidence in development plans, and to strengthen their position in deal making.

Modular approach

Our core methodology is a modular landscape, strategy definition, and validation technique that can be adapted to assets at any development stage: 

• A comprehensive or basic pricing and market access landscape assessment from a global or sub-global perspective that will help clients understand the market and develop strategies
• Pricing, data generation, HTA and contracting strategy and assumption development that will strengthen our clients’ valuations and improve their market access narrative
• Validation through primary payer research, economic modelling and secondary quantitative validation techniques will add robustness to our clients’ assumptions and strategy

What you need, when you need it

Our pricing and market access service is tailored towards development stage and deal making and complements our other deal making capabilities.

PharmaVentures can provide clients with exactly what they need, as an addition to an existing project or as a stand-alone pricing and market access study.